**What is already known**

Previous studies reported that postresuscitation hyperoxemia was an harmful independent predictor.

**What is new in the current study**

Hyperoxemia in early postresuscitation phase was not associated with survival and good neurological outcome to hospital discharge for patients with in-hospital cardiac arrest.

INTRODUCTION
============

Current American Heart Association (AHA) guidelines for adult cardiopulmonary resuscitation (CPR) recommend 100% inspired oxygen during resuscitative efforts to maximize the likelihood of achieving return of spontaneous circulation (ROSC). After ROSC is achieved, the International Liaison Committee on Resuscitation guidelines advocate a controlled reoxygenation strategy targeting an arterial oxygen saturation of 94% to 96% \[[@b1-ceem-14-017],[@b2-ceem-14-017]\]. Experimental evidence suggests that routine administration of high concentrations of O~2~ can contribute to significant neurological injury after ROSC and that even short periods of postresuscitative hyperoxemia may cause oxidative neuronal injury and worsen the neurological outcome \[[@b3-ceem-14-017]-[@b8-ceem-14-017]\].

Several clinical trials have investigated postresuscitative O~2~ therapy after cardiac arrest. In two large retrospective studies of adult patients admitted to the intensive care unit (ICU) after resuscitation from cardiac arrest, Kilgannon et al. \[[@b9-ceem-14-017],[@b10-ceem-14-017]\] reported that postresuscitation hyperoxemia was an independent predictor of mortality and poor neurological outcome, and that the relationship was dose-dependent. However, in their study, the measured variables were based only on the first PaO~2~ value at an unspecified time within 24 hours of admission. Several important variables known to influence survival after CPR, such as CPR duration and initial rhythm, were not adjusted for in their study \[[@b11-ceem-14-017]-[@b14-ceem-14-017]\]. In contrast, observational data suggest that hyperoxemia has no robust or consistently reproducible relationship with mortality \[[@b15-ceem-14-017]\]. One randomized prospective clinical trial compared the effect of ventilation for the first 60 minutes with a fraction of inspired oxygen (FiO~2~) of 0.3 and 1.0 and found no significant difference in outcomes at hospital discharge after ROSC following out-of-hospital cardiac arrest \[[@b16-ceem-14-017]\]. Some experimental data had shown that post-ischemic hyperbaric oxygen can afford neuroprotection after experimental cardiac arrest-induced complete global ischemia \[[@b17-ceem-14-017]-[@b19-ceem-14-017]\].

Oxygen plays complex biological roles, and it is difficult to define the effects on outcome after both hypoxemia and hyperoxemia. This study was implemented to test the hypothesis that early exposure to hyperoxemia is adversely associated with the clinical outcome after ROSC from in-hospital cardiac arrest.

METHODS
=======

This was a retrospective observational study of patients with ROSC after in-hospital cardiac arrest in our cardiac arrest database, which contains data from two hospitals from January 2005 to January 2011.

The CPR team of our hospital comprises an emergency physician, nurses, and paramedics who are certified as AHA-accredited advanced cardiac life-support providers. They respond to most cases of in-hospital cardiac arrest, except for cases in the ICU, which are treated by intensivists within the ICU. Patients were excluded if they were younger than 17 years or had traumatic cardiac arrest or were under percutaneous cardio-pulmonary support (PCPS) at the moment of cardiac arrest. We retrospectively reviewed the medical records of adult patients with ROSC after in-hospital non-traumatic cardiac arrest.

This study was approved by the Institutional Review Board of Hallym University Sacred Heart Hospital. We retrospectively analyzed a historical data set that was drawn from the in-hospital CPR registry between 2005 and 2011 according to Utstein style guidelines \[[@b20-ceem-14-017]\]. Additional data were collected from electronic medical records: socio-demographics, comorbidities, cause of cardiac arrest, CPR duration, place of cardiac arrest, initial monitored rhythm, survival to hospital discharge (alive or dead), and neurological status at hospital discharge \[[@b21-ceem-14-017]\]. The severity of organ dysfunction was measured using the Sequential Organ Failure Assessment (SOFA) before the cardiac arrest.

We categorized oxygenation levels into the same three groups as in the EMShockNet study \[[@b10-ceem-14-017]\]. Patients were classified into three groups based on the results of the first (within 10 minutes of ROSC) arterial blood gas analysis (ABGA) and the second ABGA from 60 minutes to 120 minutes after ROSC. Hyperoxemia was defined as PaO~2~ of ≥300 mmHg \[[@b22-ceem-14-017]\]; hypoxemia as PaO~2~ of \<60 mmHg (or ratio of PaO~2~ to FIO~2~ \<300) \[[@b23-ceem-14-017]\]; and normoxemia, as cases not classified as hyperoxemia or hypoxemia.

Cases where the results of the first and second ABGA were classified into different groups were excluded from the study.

The primary outcome of the current study was survival to hospital discharge. The secondary outcome measure was a "good outcome" defined as discharge to home or an acute rehabilitation facility. Good outcome was defined as a summation of Cerebral Performance Category (CPC) of 1 or 2 with survival to hospital discharge.

Continuous variables are expressed as the mean±standard deviation (SD) and median with interquartile range (IQR). Categorical data are reported as percentage and 95% confidence interval (CI). The Wilcoxon rank-sum test or the Kruskal-Wallis test was used to compare continuous variables, and the chi-square test or Fisher exact test was used to compare categorical variables. The occurrence of the primary outcome was compared between the groups using the chi-square test. We also performed univariate analysis using the chi-square test or Fisher exact test for nominal variables, the t-test for means, and the Mann-Whitney U-test for medians to assess the correlations between survival and several variables and between good neurological outcome and several variables. Hyperoxemia and other factors that were significantly associated with survival to discharge and good neurological outcome in the univariate analysis were analyzed by multivariable logistic regression analysis. P-value\<0.05 was considered significant. We used the SPSS ver. 18 (SPSS Inc., Chicago, IL, USA) for all statistical analyses.

RESULTS
=======

There were 2,644 patients who had in-hospital cardiac arrest. Of these, 1,852 patients (70%) were excluded: 1,420 (53.7%) had no ROSC, 196 (7.4%) were younger than 17 years, 52 (3.9%) were supported by PCPS, 116 (2.4%) belonged to different groups in the first and second ABGA results, 42 (1.6%) experienced traumatic arrest, and 26 (1.0%) had missing arterial blood gas data ([Fig. 1](#f1-ceem-14-017){ref-type="fig"}). ROSC was achieved in 1,224 cases (46.3%). The number of surviving patients at discharge was 272 (10.3%), and the number of patients who had good neurological outcome was 196 (7.4%) of in-hospital cardiac arrest.

Seven hundred and ninety-two adults were included in this study. The mean age of the patients was 63.6±11.5 years, and 64.6% were men. Six hundred and thirty-eight patients (80.6%) were classified into the hypoxemia group, 92 (11.6%) into the hyperoxemia group, and 62 (7.8%) into the normoxemia group. The baseline characteristics are presented in [Tables 1](#t1-ceem-14-017){ref-type="table"}, [2](#t2-ceem-14-017){ref-type="table"}. The three groups differed significantly in sex distribution, SOFA score, and place of cardiac arrest. Patients with normoxia had less severe illness as reflected in lower baseline SOFA scores than the hypoxemia group (P\<0.05). Normoxemia was more frequent in patients who experienced cardiac arrest in the ICU (P\<0.001), and hypoxemia was more frequent in those who experienced cardiac arrest in the ward (P\<0.001).

After ROSC, 34.3% of the patients survived to discharge, and 24.7% had good neurological outcome. Hyperoxemia was not significantly associated with survival to discharge (P=0.19) or with good neurological outcome at the time of discharge (P=0.33) ([Table 3](#t3-ceem-14-017){ref-type="table"}).

In univariate analysis, age, SOFA score, cause of arrest, CPR duration, and shockable rhythm were significantly associated with survival to discharge and good neurological outcome. PaO~2~, age, SOFA score, cause of arrest, CPR duration, and shockable rhythm were included in the multivariable logistic regression analysis. Early exposure to hyperoxemia was not significantly associated with survival to discharge and good neurological outcome after adjusting for all other significant factors ([Tables 4](#t4-ceem-14-017){ref-type="table"}, [5](#t5-ceem-14-017){ref-type="table"}).

Age, CPR duration, shockable rhythm, and SOFA score were significantly associated with survival to discharge and good neurological outcome ([Tables 4](#t4-ceem-14-017){ref-type="table"}, [5](#t5-ceem-14-017){ref-type="table"}). The Hosmer-Lemeshow goodness-of-fit P-values were 0.674 and 0.622, respectively.

DISCUSSION
==========

In the current study, hyperoxemia was relatively uncommon in the provision of ROSC after in-hospital cardiac arrest, and the PaO~2~ of the first ABGA within 10 minutes and the second ABGA from 60 to 120 minutes after ROSC were not associated with survival to discharge or good neurological outcome for in-hospital cardiac arrest patients. Hyperoxemia was not significantly associated with survival to discharge or with good neurological outcome in the univariate or multiple regression analyses.

Our results differ from those of recent large multicenter cohort studies of Project IMPACT database adult patients by Kilgannon et al. \[[@b9-ceem-14-017],[@b10-ceem-14-017]\]. There are several important differences between these prior studies and our study. First, Kilgannon et al. \[[@b9-ceem-14-017],[@b10-ceem-14-017]\] analyzed only the first ICU ABGA within 24 hours after ROSC. Although the duration of exposure to hyperoxemia may be critical, the study did not analyze the time. Another large multicenter cohort study also attempted to correlate the lowest blood gas measurement with the mean PaO~2~ in the first 24 hours, and the duration of exposure to hyperoxemia was not identified in the study \[[@b15-ceem-14-017]\]. We performed the first ABGA within 10 minutes and the second ABGA from 60 to 120 minutes after ROSC to analyze the effects of hyperoxemia in the early resuscitation phase. Even though continuous SpO~2~ monitoring and oxygen back-up were not measured during the early resuscitation phase, we included only those patients classified into the same subgroup in the first and second ABGA. The median time did not differ significantly between the PaO~2~ subgroups, and the median time between the first and second ABGA was 70 minutes (IQR, 64 to 86.2). The time may be the duration of exposure to hyperoxemia in the hyperoxemia group.

Second, the SOFA score, CPR duration, and shockable rhythm were uncontrolled in the previous studies \[[@b9-ceem-14-017],[@b10-ceem-14-017]\]. CPR duration and rhythm have also been associated with survival to discharge from hospital after ROSC in clinical trials \[[@b12-ceem-14-017],[@b13-ceem-14-017],[@b24-ceem-14-017]\]. In our study, CPR duration had a wide range (median, 10 minutes; IQR, 5 to 19), and CPR duration and rhythm were strong factors for survival. In our multiple regression analysis, we controlled for known important factors for survival such as CPR duration, shockable rhythm, and SOFA score and found that PaO~2~ was not a significant predictor \[[@b11-ceem-14-017]-[@b14-ceem-14-017]\].

In the initial reperfusion phase, autoregulation of cerebral blood flow is impaired for some time after cardiac arrest, and hypoxemia can compromise cerebral oxygen delivery and possibly cause secondary injury after cardiac arrest \[[@b19-ceem-14-017]\]. In neonatal resuscitation, 100% O~2~ is deleterious to the brain \[[@b25-ceem-14-017]\]. However, because infants have compromised antioxidant defenses and because of age-related differences in endogenous defenses against hypoxemia, the risk of 100% O~2~ may be magnified considerably in neonates compared with adults \[[@b26-ceem-14-017]\]. Experimental studies on early hyperoxemia after resuscitation from experimental cardiopulmonary arrest have shown deleterious effects \[[@b27-ceem-14-017],[@b28-ceem-14-017]\]. However, we emphasize that the experimental data reflect the effect of hyperoxemic reperfusion on ischemic brain injury in healthy animals. This is very different from the clinical situation, because many patients with cardiac arrest are not young and have multiple comorbidities. In our study, the mean (±SD) age was 63.6±11.5 years; 316 patients (39.9%) had chronic heart disease and 254 patients (32.1%) had malignancy. On the contrary, there were 182 healthy patients (23%) without any comorbidity. Such chronically ill patients may require a high FiO~2~ for adequate oxygenation. Several studies reveal that ventilation with 100% O~2~ for the first hour after ROSC can produce worse neurological outcomes than immediate adjustment of the FiO~2~ to produce an O~2~ arterial saturation of 94% to 96% \[[@b3-ceem-14-017],[@b4-ceem-14-017],[@b6-ceem-14-017]-[@b8-ceem-14-017],[@b29-ceem-14-017]\]. However, this controlled reoxygenation strategy has yet to be studied in clinical trials.

In our study, after controlling for several factors and classifying patients according to the two ABGAs, early exposure to hyperoxemia after ROSC subsequent to in-hospital cardiac arrest was not associated with survival and good neurological outcome.

However, several limitations of this work should be noted. First, this was an observational study. Further studies involving randomized prospective clinical trials are needed to understand fully the effects of hyperoxemia after ROSC. Second, we excluded patients with PCPS during CPR. In our pilot study, patients with PCPS had a high O~2~ level and survival compared with those treated with conventional CPR \[[@b30-ceem-14-017],[@b31-ceem-14-017]\]. Because therapeutic hypothermia was not widely applied in this cohort, we did not investigate the role of therapeutic hypothermia, which is recommended in treating cardiac arrest of cardiac origin \[[@b30-ceem-14-017]\]. Identifying the additive or synergistic effects of hypothermia and PCPS requires further study. Third, we have focused on the concern about the potential adverse effects of early hyperoxemia after resuscitation from cardiac arrest. However, our study did not have similar patient sets for post-ROSC hyperoxemia or normoxemia for outcomes comparison; this is because our study results were from a two-center experience with a relatively small population. Fourth, data were collected in two hospitals over six years, and the enrolled number of patients may be too small to draw a statistically powerful conclusion. Further multicenter study is necessary to confirm this result. Fifth, we could not confirm the exact duration of hyperoxemia, and those who had different results between the two consecutive ABGAs were arbitrarily excluded. This exclusion may have resulted in a selection bias to some degree. Sixth, we did not perform a six-month follow-up and cannot draw definite conclusions about the long-term outcomes.

In summary, our study showed that exposure to hyperoxemia in the early postresuscitation phase was not associated with better survival and good neurological outcome to hospital discharge for patients with ROSC after in-hospital cardiac arrest.
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![In-hospital cardiac arrest patients between January 2005 and January 2011. CA, cardiac arrest; ROSC, return to spontaneous circulation; PCPS, percutaneous cardiopulmonary support.](ceem-14-017f1){#f1-ceem-14-017}

###### 

Demographic characteristics of the study patients

  Variable                     Total (n=792)    First and second ABGA PaO~2~                                                           
  ---------------------------- ---------------- ------------------------------ ------------------------------------------------------- ----------------
  Age (yr), mean±SD            63.6± 11.5       64.4±10.4                      67.1±9.1                                                62.6± 10.5
  Male                         512 (64.6)       55 (60.0)                      26 (41.9)[^a)^](#tfn3-ceem-14-017){ref-type="fn"}       411 (64.4)
  Comorbidities                                                                                                                        
   Diabetes mellitus           266 (33.6)       28 (30.4)                      20 (32.3)                                               218 (34.1)
   Hypertension                286 (36.1)       28 (30.4)                      22 (35.5)                                               236 (37.0)
   Chronic renal disease       120 (15.2)       14 (15.2)                      10 (16.1)                                               96 (15.0)
   Chronic heart disease       316 (39.9)       46 (50.0)                      30 (48.4)                                               240 (37.6)
   Chronic hepatic disease     126 (15.9)       16 (17.4)                      6 (9.7)                                                 104 (16.3)
   Malignancy                  254 (32.1)       26 (28.3)                      14 (22.6)                                               214 (33.5)
   Respiratory insufficiency   74 (9.4)         10 (10.9)                      4 (6.5)                                                 60 (9.4)
   Stroke                      82 (10.4)        8 (8.7)                        8 (12.9)                                                66 (10.3)
  SOFA score, median (IQR)     5.0 (3.8-10.0)   5.0 (3.0-8.3)                  5.0 (2.0-9.0)[^b)^](#tfn4-ceem-14-017){ref-type="fn"}   7.0 (4.0-10.0)

Values are presented as number (%) unless otherwise indicated.

ABGA, arterial blood gas analysis; SOFA, Sequential Organ Failure Assessment.

P=0.02 for comparison of normoxemia with hypoxemia.

P=0.04 for comparison of normoxemia with hypoxemia.

###### 

Descriptive data of cardiac arrest

  Variable                                  Total (n=792)   First and second ABGA PaO~2~                                                       
  ----------------------------------------- --------------- ------------------------------ --------------------------------------------------- --------------
  Initial shockable rhythm                  156 (20.8)      20 (25)                        18 (31)                                             118 (19.3)
  Place of cardiac arrest                                                                                                                      
   Intensive care unit                      228 (28.8)      24 (26.1)                      30 (48.4)[^a)^](#tfn7-ceem-14-017){ref-type="fn"}   174 (27.3)
   Ward                                     342 (43.2)      34 (37.0)                      10 (16.1)[^a)^](#tfn7-ceem-14-017){ref-type="fn"}   298 (46.7)
   Other                                    222 (28.0)      34 (37.0)                      22 (35.5)                                           166 (26.0)
  CPR duration (min)                        14.2±14.7       16.3±15.0                      11.2± 12.1                                          14.1±14.9
  Cause of arrest                                                                                                                              
   Cardiac                                  236 (29.8)      30 (32.6)                      24 (38.7)                                           182 (28.5)
   Respiratory                              172 (21.7)      26 (28.3)                      4 (6.5)                                             142 (22.3)
   Other                                    384 (48.5)      36 (39.1)                      34 (54.8)                                           314 (49.2)
  Time between the 1st and 2nd ABGA (min)   70 (64-86.2)    74.5 (65.1-88.3)               71 (68.5-98.5)                                      63 (61-70.2)

Values are presented as number (%), mean±SD, or median (interquartile range).

ABGA, arterial blood gas analysis; CPR, cardiopulmonary resuscitation; IQR, interquartile range.

P\<0.001 for comparison of normoxemia with hypoxemia.

###### 

Outcomes of the study patients

  Outcome                     Total (n=792)   First and second PaO~2~                            
  --------------------------- --------------- ------------------------- ----------- ------------ ------
  Survival discharge          272 (34.3)      34 (37.0)                 30 (48.4)   208 (32.6)   0.19
  Good neurological outcome   196 (24.7)      24 (26.1)                 22 (35.5)   150 (23.5)   0.33

Values are presented as number (%).

###### 

Multivariable logistic regression and odds ratios of survival to hospital discharge

  Variable                              Odds ratio         95% CI      P-value
  ------------------------------------- ------------------ ----------- ---------
  Age                                   0.96               0.94-0.99   0.002
  Sequential organ failure assessment   0.59               0.19-0.79   0.01
  Cause of arrest                                                      
   Cardiac origin                       2.33               0.42-2.57   0.44
   Respiratory origin                   0.29               0.25-1.41   0.96
  CPR duration                          0.89               0.86-0.93   \<0.001
  Shockable rhythm                      1.94               1.43-2.14   0.002
  First and second ABGA PaO~2~                                         
   Normoxia                             1.00 (reference)               
   Hyperoxemia                          1.03               0.31-3.40   0.96
   Hypoxemia                            0.70               0.28-1.73   0.44

CI, confidence interval; CPR, cardiopulmonary resuscitation; ABGA, arterial blood gas analysis.

###### 

Multivariable logistic regression and odds ratios of good neurological outcome at hospital discharge

  Variable                              Odds ratio         95% CI      P-value
  ------------------------------------- ------------------ ----------- ---------
  Age                                   0.95               0.92-0.98   \<0.001
  Sequential organ failure assessment   0.52               0.16-0.78   0.07
  Cause of arrest                                                      
   Cardiac origin                       1.55               0.54-4.47   0.42
   Respiratory origin                   0.66               0.55-1.02   0.37
  CPR duration                          0.88               0.84-0.93   \<0.001
  Shockable rhythm                      1.63               1.42-2.26   0.002
  First and second ABGA PaO~2~                                         
   Normoxia                             1.00 (reference)               
   Hyperoxemia                          1.07               0.30-3.84   0.91
   Hypoxemia                            1.00               0.37-2.70   0.97

CI, confidence interval; CPR, cardiopulmonary resuscitation; ABGA, arterial blood gas analysis.
